½ÃÀ庸°í¼­
»óǰÄÚµå
1547364

¼¼°èÀÇ NGS »ùÇà Á¶Á¦ ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)

Global NGS Sample Preparation Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 170 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

NGS »ùÇà Á¦Á¶ ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 16.76%·Î, 2023³âÀÇ 15¾ï 4, 000¸¸ ´Þ·¯¿¡¼­ 2032³â¿¡´Â ¾à 62¾ï 3, 000¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

NGS(Â÷¼¼´ë ½ÃÄö½Ì) »ùÇà Á¶Á¦´Â À¯Àü ¹°ÁúÀ» ºÐ¼®Çϱâ À§ÇÑ ½ÃÄö½ÌÀ» À§ÇÑ »ý¹°ÇÐÀû ½Ã·á¸¦ ÁغñÇÕ´Ï´Ù. ÀÌ Àü󸮿¡´Â ¼¼Æ÷¿¡¼­ DNA ¶Ç´Â RNA ÃßÃâ, ÇÙ»ê ºÐÀý, ½ÃÄö½Ì ¾î´ðÅÍÀÇ Ã·°¡ µî ¸î °¡Áö Áß¿äÇÑ ´Ü°è°¡ Æ÷ÇԵ˴ϴÙ. ÁغñµÈ »ùÇÃÀº ÁõÆøµÇ¾î ½ÃÄö½Ì °¡´ÉÇÑ ¶óÀ̺귯¸®°¡ »ý¼ºµË´Ï´Ù. NGS »ùÇà Á¶Á¦ÀÇ ¹ßÀüÀ¸·Î ¿öÅ©Ç÷ο찡 °£¼ÒÈ­µÇ°í, È¿À²¼ºÀÌ Çâ»óµÇ°í, ºñ¿ëÀÌ Àý°¨µÇ°í, À¯ÀüüÇÐ, Á¾¾çÇÐ, °¨¿°, °³ÀÎÈ­µÈ ÀÇ·á¿¡ ´ëÇÑ ÀÀ¿ëÀ» À§ÇÑ °í¼º´É ½ÃÄö½ÌÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. Á¤È®ÇÑ »ùÇà Á¶Á¦´Â ½Å·ÚÇÒ ¼ö ÀÖ´Â ½ÃÄö½Ì µ¥ÀÌÅ͸¦ ¾ò°í À¯ÀüÀÚ º¯ÀÌ, Áúº´ ¸ÞÄ¿´ÏÁò ¹× ÁøÈ­ »ý¹°Çп¡ ´ëÇÑ Áö½ÄÀ» ¾ò´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ

¿¬±¸ ¹× ÀÓ»ó ÇöÀå¿¡¼­ Â÷¼¼´ë ½ÃÄö¼­(NGS) ±â¼úÀÇ È°¿ë È®´ë´Â Á¾ÇÕÀûÀÎ À¯Àüü Á¤º¸¸¦ ½Å¼ÓÇÏ°í ºñ¿ë È¿À²ÀûÀ¸·Î Á¦°øÇÏ´Â ´É·Â¿¡ ÀÇÇØ ÃßÁøµÇ°í ÀÖÀ¸¸ç, ÀÌ´Â NGS »ùÇà Á¶Á¦ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ÀÚµ¿È­ Ç÷§Æû°ú ÃÖÀûÈ­µÈ ÇÁ·ÎÅäÄÝÀ» Æ÷ÇÔÇÑ »ùÇà Á¶Á¦ ±â¼úÀÇ Áøº¸´Â NGS ¿öÅ©Ç÷οìÀÇ È¿À²¼º°ú Á¤È®¼ºÀ» Çâ»ó½ÃÄÑ ½ÃÀå ¼ö¿ä¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. À¯ÀüÀÚ ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ÁÖ¸ñÀº °í¼º´É, ½Å·Ú¼º ³ôÀº NGS »ùÇà Á¶Á¦ ¹æ¹ýÀÇ Çʿ伺À» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ À¯Àüü ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ½ÃÄö½Ì ´É·Â È®´ë°¡ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

Çмú±â°ü, ¿¬±¸±â°ü, »ý¸í°øÇÐ ±â¾÷ °£ÀÇ °øµ¿ ¿¬±¸´Â ±â¼ú Çõ½Å°ú »õ·Î¿î NGS »ùÇà Á¶Á¦ ¼Ö·ç¼ÇÀÇ °³¹ßÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÓ»ó Áø´Ü¿¡¼­ NGSÀÇ »ç¿ë¿¡ ´ëÇÑ ±ÔÁ¦ Áö¿ø°ú NGS¸¦ ÀÏ»óÀûÀÎ ÀÇ·á ÇàÀ§¿¡ ÅëÇÕÇÏ´Â ÁøÇàÁßÀÎ µ¿ÇâÀº ½ÃÀå È®´ë¸¦ ´õ¿í °­È­Çϰí ÀÖ½À´Ï´Ù. Á¾¾çÇÐ, °¨¿°Áõ Áø´Ü, »ý½Ä ÀÇ·á µî NGSÀÇ »õ·Î¿î ¿ëµµ°¡ Â÷·Ê·Î °³¹ßµÇ°í ÀÖ´Â °Íµµ È¿À²ÀûÀÎ »ùÇà Á¶Á¦ ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÃÄö½Ì ±â¼úÀÇ °íºñ¿ë, °íµµ·Î ¼÷·ÃµÈ ÀηÂÀÇ Çʿ伺, µ¥ÀÌÅÍ ºÐ¼®ÀÇ º¹À⼺Àº ÇâÈÄ ¼ö³â°£ ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

Á¶»ç º¸°í¼­´Â Porter's Five Force ¸ðµ¨, ½ÃÀå ¸Å·Â ºÐ¼® ¹× ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ì´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â NGS »ùÇà Á¶Á¦ ½ÃÀå ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. NGS »ùÇà Á¶Á¦ ½ÃÀå »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ ´ëÇÑ Àü¹ÝÀûÀÎ Á¢±Ù¹ýÀ» ¼³¸íÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

NGS »ùÇà Á¶Á¦ ½ÃÀå ½ÃÀå ¼¼ºÐÈ­´Â ±¹°¡ ¹× Áö¿ªº° ºÎ¹®¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÔÀ¸·Î½á Àü·« ´ã´çÀÚ°¡ °¢ Á¦Ç° ¶Ç´Â ¼­ºñ½ºÀÇ ´ë»ó °èÃþÀ» ÆÄ¾ÇÇϰí ÇâÈÄ ºñÁî´Ï½º ±âȸ¿¡ µµ¿òÀ» ÁÙ ¼ö ÀÖÀ½ ¼ö ÀÖ½À´Ï´Ù.

Áö¿ª ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­ NGS »ùÇà Á¶Á¦ ½ÃÀå¿¡ ´ëÇÑ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ ÀÌ º¸°í¼­´Â ¸ðµç ÁÖ¿ä Áö¿ª¿¡¼­ °³º° ¿ëµµ ºÎ¹®¿¡ ´ëÇÑ ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÁßÁ¡À» µÓ´Ï´Ù.

¸ÂÃ㠿䱸»çÇ×ÀÌ ÀÖ´Â °æ¿ì Google¿¡ ¹®ÀÇÇϼ¼¿ä. ´ç»çÀÇ ¼³¹®Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®
  • ½ÃÀå ÇöȲ

Á¦3Àå NGS »ùÇà Á¶Á¦ ½ÃÀå - »ê¾÷ ºÐ¼®

  • ¼Ò°³ : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü À϶÷
    • ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀ̾î À϶÷
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå »ùÇà Á¶Á¦ ½ÃÀå ºÐ¼® : Á¦Ç° À¯Çüº°

  • Á¦Ç° À¯Çüº° °³¿ä
  • Á¦Ç° À¯Çüº° °ú°Å ¹× ¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • ÀåÄ¡
  • ŰƮ, ½Ã¾à, ¼Ò¸ðǰ

Á¦6Àå »ùÇà Á¶Á¦ ½ÃÀå ºÐ¼® : ¿ëµµº°

  • ¿ëµµº° °³¿ä
  • ¿ëµµº° °ú°Å ¹× ¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • â¾à°ú ¹ÙÀÌ¿À¸¶Ä¿ Ž»ö
  • Áø´Ü¾à
  • Á¤¹ÐÀÇ·á
  • ±âŸ(³ó¾÷ ¹× µ¿¹° ¿¬±¸)

Á¦7Àå ¼¼°èÀÇ NGS »ùÇà Á¶Á¦ ½ÃÀå ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°

  • ÃÖÁ¾ »ç¿ëÀÚº° °³¿ä
  • ÃÖÁ¾ »ç¿ëÀÚº° °ú°Å ¹× ¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • º´¿ø, ÀÓ»ó Áø´Ü¼¾ÅÍ
  • ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö, Á¦¾à±â¾÷
  • Çмú±â°ü ¹× ¿¬±¸±â°ü
  • ±âŸ(CRO, CMO µî)

Á¦8Àå NGS »ùÇà Á¶Á¦ ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼Ò°³
  • ºÏ¹Ì ¸ÅÃ⠺м®
    • °³¿ä : ºÐ¼® ¹× ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ ¸ÅÃ⠺м®
    • °³¿ä : ºÐ¼® ¹× ¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ¸ÅÃ⠺м®
    • °³¿ä : ºÐ¼® ¹× ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä : ºÐ¼® ¹× ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä : ºÐ¼® ¹× ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º° À϶÷
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå NGS »ùÇà Á¶Á¦ ½ÃÀå ±â¾÷°æÀï ±¸µµ

  • NGS »ùÇà Á¶Á¦ ½ÃÀå ½ÃÀå °æÀï
  • ÆÄÆ®³Ê½Ê/Á¦ÈÞ/ÇÕÀÇ
  • ÇÕº´ ¹× Àμö
  • ½ÅÁ¦Ç° ¹ßÇ¥
  • ±âŸ °³¹ß

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Qiagen
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • F. Hoffmann-La Roche Ltd.
  • Agilent Technologies
  • Promega Corporation
  • Illumina Inc.
  • Integrated DNA Technologies Inc.
  • New England Biolabs
  • Tecan Trading AG
BJH 24.09.24

The global demand for NGS Sample Preparation Market is presumed to reach the market size of nearly USD 6.23 Billion by 2032 from USD 1.54 Billion in 2023 with a CAGR of 16.76% under the study period 2024-2032.

NGS (Next-Generation Sequencing) sample preparation prepares biological samples for sequencing to analyze genetic material. This preparation involves several key steps: extracting DNA or RNA from cells, fragmenting the nucleic acids, and adding adapters for sequencing. The prepared samples are then amplified to create a library that can be sequenced. Advances in NGS sample preparation have streamlined workflows, increased efficiency, and reduced costs, enabling high-throughput sequencing for applications in genomics, oncology, infectious diseases, and personalized medicine. Accurate sample preparation is crucial for obtaining reliable sequencing data and achieving insights into genetic variations, disease mechanisms, and evolutionary biology.

MARKET DYNAMICS

The growing use of next-generation sequencing (NGS) technologies in research and clinical settings is driven by their capacity to provide comprehensive genomic information quickly and cost-effectively, which is driving the growth of the NGS sample preparation market. Advancements in sample preparation techniques, such as automated platforms and optimized protocols, are improving the efficiency and accuracy of NGS workflows, thereby boosting market demand. Genetic disorders' rising prevalence and focus on personalized medicine propel the need for high-throughput and reliable NGS sample preparation methods. Additionally, increasing investments in genomic research and expanding sequencing capabilities in emerging markets contribute to market growth.

Collaborations between academic institutions, research organizations, and biotechnology companies are fostering innovation and the development of novel NGS sample preparation solutions. Regulatory support for using NGS in clinical diagnostics and the ongoing trend of integrating NGS into routine medical practice further drive market expansion. The continuous development of new applications for NGS, such as in oncology, infectious disease diagnostics, and reproductive health, is also enhancing the demand for efficient sample preparation technologies. However, the high costs of sequencing technologies, the need for highly skilled personnel, and the complexity of data analysis may hinder market growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of NGS Sample Preparation Market. The growth and trends of NGS Sample Preparation Market industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the NGS Sample Preparation Market market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Instruments
  • Kits, Reagents, and Consumables

By Application

  • Drug and Biomarker Discovery
  • Diagnostics
  • Precision Medicine
  • Others (agriculture and animal research)

By End-user

  • Hospitals & Clinical Diagnostic Centers
  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutes
  • Others (CROs, CMOs etc)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the NGS Sample Preparation Market market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the NGS Sample Preparation Market market include Qiagen, Thermo Fisher Scientific Inc., Merck KGaA, F. Hoffmann-La Roche Ltd., Agilent Technologies, Promega Corporation, Illumina Inc., Integrated DNA Technologies Inc., New England Biolabs, Tecan Trading AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. NGS SAMPLE PREPARATION MARKET - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL NGS SAMPLE PREPARATION MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data Analysis By Product Type
  • 5.3. Instruments Historic and Forecast Sales By Regions
  • 5.4. Kits, Reagents, and Consumables Historic and Forecast Sales By Regions

6. GLOBAL NGS SAMPLE PREPARATION MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Drug and Biomarker Discovery Historic and Forecast Sales By Regions
  • 6.4. Diagnostics Historic and Forecast Sales By Regions
  • 6.5. Precision Medicine Historic and Forecast Sales By Regions
  • 6.6. Others (agriculture and animal research) Historic and Forecast Sales By Regions

7. GLOBAL NGS SAMPLE PREPARATION MARKET ANALYSIS BY END-USER

  • 7.1. Overview By End-user
  • 7.2. Historical and Forecast Data Analysis By End-user
  • 7.3. Hospitals & Clinical Diagnostic Centers Historic and Forecast Sales By Regions
  • 7.4. Biotechnology & Pharmaceutical Companies Historic and Forecast Sales By Regions
  • 7.5. Academic & Research Institutes Historic and Forecast Sales By Regions
  • 7.6. Others (CROs, CMOs etc) Historic and Forecast Sales By Regions

8. GLOBAL NGS SAMPLE PREPARATION MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE NGS SAMPLE PREPARATION MARKET COMPANIES

  • 9.1. NGS Sample Preparation Market Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF NGS SAMPLE PREPARATION MARKET INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Qiagen
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Thermo Fisher Scientific Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Merck KGaA
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. F. Hoffmann-La Roche Ltd.
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Agilent Technologies
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Promega Corporation
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Illumina Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Integrated DNA Technologies Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. New England Biolabs
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Tecan Trading AG
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦